from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2047c/-

LFCtreatmentdescriptionclass of inhibitor

0.832

Amikacinug/mL Amikacintranslation

0.174

Cap5-10ug/mL Capreomycintranslation

0.820

Rox10-50 ug/mL Roxithromycintranslation

-0.439

SM2-5 ug/mL Streptomycintranslation

2.591

Tet5-10 ug/mL Tetracyclinetranslation

0.840

Rif0.2-5ug/mL Rifampicintranscription

0.084

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.026

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.111

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.813

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.488

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.213

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.674

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.165

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.818

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.099

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.732

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.014

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.852

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.623

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.542

KCN5-20 ug/mL Potassium cyaniderespiration

0.213

NaN30.2-2 mM Sodium aziderespiration

-0.324

Nigericin50 uM Nigericinrespiration

0.386

TRC10-150 ug/mL Triclosanrespiration

-0.144

TRZ10-25 ug/mL Thioridazinerespiration

1.587

Valinomycin0.5-10 uM Valinomycinrespiration

-0.356

ZnSO42 mM ZnSO4respiration

0.253

menadione6-10 ug/mL Menadionerespiration

-0.139

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.470

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.491

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.169

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.474

NRP_1Non-replicating persistence stage 1dosRassociated

-0.660

Amp0.2mg/mL AmpicillincellWall

-0.276

Cephalexin20-100 ug/mL CephalexincellWall

0.351

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.173

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.353

EMB10-20 ug/mL EthambutolcellWall

0.175

Eta12-40 ug/mL EthionamidecellWall

0.158

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.136

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.200

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.449

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.053

BZA0.12 mg/mL BenzamidearomaticAmides

0.537

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.646

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.145

H2O24 mM hydrogen peroxideDNAdamaging

0.345

Levo10 ug/mL LevofloxacinDNAdamaging

-0.771

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.001

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.003

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.363

UVUV-irradiationDNAdamaging

1.577

ARP41-4 ug/mL Antitubercular compound ARP4?

0.031

Antimycin12.5-50 ug/mL Antimycin A?

-0.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.330

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.244

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.192

PA8240.2-2 ug/mL PA-824?

0.993

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.854

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.503

Verapamil50 uM Verapamil?

0.466

mercaptoethanol2 mM 2-Mercaptoethanol?

0.414

methoxatin10-20 ug/mL Methoxatin?